PanTera
PrivateLast Round
Series A
Sep 11, 2024
Est. Valuation
$308.3M
Total Funding Raised
$110.3M
Company Overview
PanTera is a life sciences company that produces actinium-225, a radioisotope used in next-generation radiopharmaceuticals for targeted cancer therapy.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PanTera Comparables
Compare PanTera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AlfaRim Medical | 85% | |
| Niowave Inc. | 79% | |
| Nusano | 78% | |
PanTera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 11, 2024 | ||||
| Debt | Sep 11, 2024 | ||||
| Convertible Debt | Sep 22, 2022 |
PanTera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Convertible Debt, Series A |
| EQT Life Sciences | Series A |
| Korys | Series A |
| Paladin Capital Group | Series A |
| KBC Group N.V. | Debt |
| PMV | Series A |
| Eurazeo | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 22, 2025
Grew 19% QoQ, from 42 to 50 employees.
- Nov 7, 2025
Monthly visitors increased 50% MoM.
PanTera Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PanTera's valuation, stock price, and market status.